Statins and Left Ventricular Ejection Fraction Following Doxorubicin Treatment

Autor: Hundley, W. Gregory, D’Agostino, Ralph, Crotts, Teresa, Craver, Karen, Hackney, Mary Helen, Jordan, Jennifer H., Ky, Bonnie, Wagner, Lynne I., Herrington, David M., Yeboah, Joseph, Reding, Kerryn W., Ladd, Amy C., Rapp, Stephen R., Russo, Sandra, O’Connell, Nathaniel, Weaver, Kathryn E., Dressler, Emily V., Ge, Yaorong, Melin, Susan A., Gudena, Vinay, Lesser, Glenn J.

Publikováno v: NEJM Evid

BACKGROUND: Statins taken for cardiovascular indications by patients with breast cancer and lymphoma during doxorubicin treatment may attenuate left ventricular ejection fraction (LVEF) decline, but the effect of statins on LVEF among patients with n

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96ba74a1a547957ea54dd9ccaf2fb1ca
https://doi.org/10.1056/evidoa2200097

Pediatric Cancer By Race, Ethnicity and Region in the United States.

Autor: Rees, Judy R., Weiss, Julie E., Riddle, Bruce L., Craver, Karen, Zens, Michael Scot, Celaya, Maria O., Peacock, Janet L.

Publikováno v: Cancer Epidemiology, Biomarkers & Prevention; Oct2022, Vol. 31 Issue 10, p1896-1906, 11p

Simplified assay for VWF cleaving protease (ADAMTS13) activity and inhibitor in plasma.

Autor: Knovich MA; Section on Hematology and Oncology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA. mknovich@wfubmc.edu, Craver K, Matulis MD, Lawson H, Owen J

Publikováno v: American journal of hematology [Am J Hematol] 2004 Jul; Vol. 76 (3), pp. 286-90.